|
I. Leukemias, myeloproliferative diseases, and myelodysplastic diseases
|
1305
|
1143
|
0.89 (0.88–0.91)
|
0.87
|
1.00
|
0.99
|
0.94
|
|
II. Lymphomas and reticuloendothelial neoplasms
|
585
|
554
|
0.90 (0.88–0.92)
|
0.89
|
0.99
|
0.94
|
0.98
|
|
III. CNS and miscellaneous intracranial and intraspinal neoplasms
|
790
|
757
|
0.95 (0.94–0.96)
|
0.94
|
1.00
|
0.98
|
0.99
|
|
IV. Neuroblastoma and other peripheral nervous cell tumors
|
262
|
256
|
0.97 (0.96–0.99)
|
0.96
|
1.00
|
0.98
|
1.00
|
|
V. Retinoblastoma
|
105
|
105
|
1.00 (1.00–1.00)
|
1.00
|
1.00
|
1.00
|
1.00
|
|
VI. Renal tumors
|
174
|
175
|
0.98 (0.96–0.99)
|
0.98
|
1.00
|
0.98
|
1.00
|
|
VII. Hepatic tumors
|
68
|
64
|
0.92 (0.88–0.97)
|
0.90
|
1.00
|
0.95
|
1.00
|
|
VIII. Malignant bone tumors
|
181
|
192
|
0.89 (0.86–0.92)
|
0.92
|
0.99
|
0.87
|
1.00
|
|
IX. Soft tissue and other extraosseus sarcomas
|
285
|
260
|
0.86 (0.82–0.89)
|
0.82
|
0.99
|
0.91
|
0.99
|
|
X. Germ cell tumors, trophoblastic tumors, and neoplasms of gonads
|
140
|
136
|
0.96 (0.93–0.98)
|
0.94
|
1.00
|
0.97
|
1.00
|
|
XI. Other malignant epithelial neoplasms and malignant melanomas
|
155
|
172
|
0.93 (0.90–0.96)
|
0.98
|
0.99
|
0.88
|
1.00
|
|
XII. Other and unspecified malignant neoplasms
|
23
|
259
|
0.06 (0.02–0.10)
|
0.43
|
0.94
|
0.04
|
1.00
|
